SCHEMBL6958489

SCHEMBL6958489

CCOC(=O)OC1=C(C(C)C)NC(C(C)C)=C(c2ccccc2)C1c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1D Q01668 3/20 0.39
CACNA1F O60840 1/20 0.39
CACNA1S Q13698 1/20 0.39
CACNA1C Q13936 1/20 0.39
BCHE P06276 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
EPHX2 P34913 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
ACHE P22303 2/20 0.36
MAPT P10636 4/20 0.35
LMNA P02545 3/20 0.35
POLB P06746 1/20 0.35
MEN1 O00255 2/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
ALOX12 P18054 1/20 0.34
CCR6 P51684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949791 0.88 CACNA1F (0.46) CACNA1DCACNA1FCACNA1SCACNA1CBCHE
SCHEMBL9359608 0.88 EPHX2 (0.41) CACNA1DCACNA1FCACNA1SCACNA1CBCHE
SCHEMBL9270856 0.85 CACNA1D (0.45) CACNA1DCACNA1FCACNA1SCACNA1CBCHE
SCHEMBL9359332 0.84 CACNA1F (0.38) CACNA1DCACNA1FCACNA1SCACNA1CBCHE
SCHEMBL9359378 0.83 ADORA3 (0.47) CACNA1DCACNA1FCACNA1SCACNA1CSMN1; SMN2
SCHEMBL9359818 0.81 CACNA1F (0.42) CACNA1DCACNA1FCACNA1SCACNA1CBCHE
SCHEMBL9363639 0.80 CACNA1D (0.41) CACNA1DCACNA1FCACNA1SCACNA1CSMN1; SMN2
SCHEMBL10518260 0.80 SMN1; SMN2 (0.47) CACNA1DCACNA1FCACNA1SCACNA1CBCHE
SCHEMBL9359615 0.78 CACNA1F (0.40) CACNA1DCACNA1FCACNA1SCACNA1CSMN1; SMN2
SCHEMBL6956368 0.78 CACNA1F (0.40) CACNA1DCACNA1FCACNA1SCACNA1CBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0325130-B1 Substituted pyridines BAYER AG (DE) 2003-11-05 EP disclosed
EP-1123924-A1 Substituted pyridines as HMG-COA reductase inhibitors BAYER AG (DE) 2001-08-16 EP disclosed
EP-1123925-A1 Process for preparation of substituted pyridines BAYER AG (DE) 2001-08-16 EP disclosed
EP-0325130-A2 Substituted pyridines BAYER AG (DE) 1989-07-26 EP disclosed